探索遗传性视网膜疾病中的质子修饰.
Luigi Mazzeo1, Yvan Arsenijevic2, Adeline Berger3
1Department of Ophthalmology, Unit of Epigenetics of ocular diseases, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland.
Advances in experimental medicine and biology
|February 10, 2025
概括
遗传性视网膜疾病 (IRD) 是一种渐进的光受体疾病,目前没有治疗方法. 表观遗传调制,特别是针对基因组修饰,为IRD提供了一个有前途的基因不可知治疗策略.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 遗传性视网膜疾病 (IRD) 导致渐进的光受体细胞死亡,缺乏有效的治疗方法.
- 尽管有遗传多样性,但常见的细胞通路受表观遗传修饰的调节,都与IRD有关.
- 表观遗传修饰是可逆的,这促使人们对IRD的基因不可知治疗方法产生兴趣.
研究的目的:
- 在遗传性视网膜疾病的背景下,审查表观遗传机制,特别是基因组修饰的作用.
- 探索表观遗传调制作为IRD的基因不可知治疗策略的潜力.
- 评估在临床前模型中用于治疗光感受器退化症的组素标记修饰剂的效率.
主要方法:
- 专注于基因表达的关键调节者,作为基因细胞的翻译后修饰.
- 对基因素标记修饰剂的机制研究的综述.
- 在IRD动物模型中评估治疗效率.
主要成果:
- 基因突变在视网膜细胞中的基因表达和染色质紧缩的调节中起着至关重要的作用.
- 在临床前研究中,质子标记修饰剂已经显示出有前途的潜力.
- 了解这些表观遗传机制可以揭示光受体退化.
结论:
- 表观遗传学调制,特别是向基因组修饰,代表了一种可行的基因不可知治疗途径,用于遗传性视网膜疾病.
- 进一步研究基因组标记修饰剂可能会导致IRD的新治疗方法.
- 这种方法对理解和治疗人类光受体细胞死亡有希望.
相关概念视频
02:32Histone Modification
13.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.0K
03:17Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
02:25Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
01:11Genetic Lingo
100.0K
Overview
100.0K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
02:30Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K